Potential new antibiotic for treating gonorrhoea

Scientists believe that they have found a new effective antibiotics for gonorrhea, which can be the most promising in decades.

You can treat gepotidacin and treat existing antibiotics along with sexually transmitted infections and some emerging drug-resistant ‘superbug’ seems capable of dealing with ‘superbugs’ strains, researchers also say that researchers say that researchers say that The Lancet Journal,

The work was funded by the pharmaceutical company GSK which creates a new tablet.

Gonorrhea is one of the most common STIs in the UK and the cases are increasing.

In 2023, more than 85,000 Gonorrhea was diagnosed in England alone – the highest number since the records started in 1918.

Most cases were curable, but there is Growing concern That some strains cannot be dealt with so easily.

Over time, the bacteria have developed resistance to most classes of antibiotics available and experts fear that it may be untreated in the future, until new drugs are found.

Untreated gonorrhea can lead to serious health issues, including pelvic inflammatory disease and infertility.

Gepotidacin works differently for other antibiotics and prevents replication by blocking two essential enzymes of gonorrhea.

It is already approved in the US to treat urinary tract infections.

The test presented at the ESCMID conference included 628 patients, which were allocated randomly to obtain gapotidasin or an existing antibiotics.

The new pill was equally effective for the treatment of gonorrhea and worked against the strains of the transition that were resistant to the current first-ride treatments, such as seftriaxone.

Side-effects were reported more frequently with gapotidasin, but they were usually mild, such as nausea or some stomach problems.

Gepotidacine is not the only new oral antibiotics for gonorrhea that researchers are discovering.

Another, called zoliflodasin, has also shown Promise in step 3 clinical trials,

Meanwhile, UK is considering One vaccine To help prevent the spread of gonorrhea.

In November 2023, the Joint Committee on vaccination and vaccination (JCVI) recommended the target roll-out of the MENB vaccine.

Mainly designed to deal with meningitis B, JCVI found that treatment was about 40% effective in preventing people from contracting and spreading gonorrhea.

Consultant Epidemiologist and head of STI section at UK Health Security Agency. Katy Sink stated that it was “really promising” to see a successful test for a new antibiotic for the treatment of gonorrhea.

“As gonorrhea becomes rapid resistant to antibiotics, it can be untreated in the future and can cause serious problems such as pelvic inflammatory disease and infertility. Such tests are very important to help us find new treatment options.”

He said that the best way to stop an STI is using a condom. If someone has a condom-less sex with a new or casual partner, they should test them.

“Initial identity not only protects a person’s health, but also prevents transmission to others. The test is quick, independent and confidential,” he said.

• Gonorrhea easily passes from person to person through unsafe sex
• About 10 of the 10 infected men and about half of infected women do not experience any symptoms
• The infection can be passed from a pregnant woman to her child, and without treatment, can cause permanent blindness for a newborn child
• It does not spread like hugging by non-sexual contact
• This toilet is not transmitted through seats, towels, cups or plates like surfaces and materials.
• If you have earlier successfully treated for gonorrhea, you can still catch it again

Source: NHS

More information and advice is available This NHS webpage,